Breaking News Instant updates and real-time market news.

LYFT

Lyft

$61.01

0.785 (1.30%)

, AAPL

Apple

$200.19

-0.46 (-0.23%)

10:16
04/11/19
04/11
10:16
04/11/19
10:16

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Lyft (LYFT) initiated with a Hold at HSBC. 2. Apple (AAPL), Dell Technologies (DELL), and HP Inc. (HPQ) initiated with a Neutral at Credit Suisse. 3. Yeti (YETI) initiated with an Outperform at Cowen. 4. CVS Health (CVS) initiated with a Market Perform at BMO Capital. 5. Canadian Solar (CSIQ) assumed with a Neutral at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

LYFT

Lyft

$61.01

0.785 (1.30%)

AAPL

Apple

$200.19

-0.46 (-0.23%)

DELL

Dell Technologies

$63.36

0.09 (0.14%)

HPQ

HP Inc.

$19.96

-0.015 (-0.08%)

YETI

Yeti

$30.93

0.79 (2.62%)

CVS

CVS Health

$54.15

0.27 (0.50%)

CSIQ

Canadian Solar

$18.49

-0.28 (-1.49%)

  • 15

    Apr

  • 23

    Apr

  • 30

    Apr

  • 01

    May

  • 02

    May

  • 07

    May

  • 08

    May

  • 30

    May

  • 03

    Jun

LYFT Lyft
$61.01

0.785 (1.30%)

04/02/19
CRSS
04/02/19
INITIATION
CRSS
Buy
Lyft initiated with a Buy at Cross Research
Cross Research analyst Steven Fox initiated Lyft with a Buy
04/05/19
DAIW
04/05/19
INITIATION
Target $80
DAIW
Buy
Lyft initiated with a Buy at Daiwa
Daiwa analyst Jairam Nathan initiated Lyft with a Buy and a $80 price target.
04/11/19
HSBC
04/11/19
INITIATION
Target $60
HSBC
Hold
Lyft initiated with a Hold at HSBC
HSBC analyst Masha Kahn started Lyft (LYFT) with a Hold rating and $60 price target. While the analyst sees a shift from car ownership to the transportation as a service model, she believes "costs need to fall dramatically" for ride-hailing to cover all transportation needs. Further, since number two players will always scale at a lower margin than dominant players, Lyft deserves a discount to other ride-hailing players that dominate their markets, Kahn tells investors in a research note. The analyst highlight Russia's Yandex (YNDX) as a "significantly less expensive way to gain exposure to ride-hailing."
04/02/19
04/02/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Lyft (LYFT) initiated with a Buy at Cross Research and a Sell at Seaport Global. 2. Dow Inc. (DOW) initiated with an Outperform at BMO Capital and Credit Suisse, an Overweight at Morgan Stanley, as well as a Buy at Deutsche Bank and BofA/Merrill. 3. Sonos (SONO) initiated with a Buy at DA Davidson. 4. Q2 Holdings (QTWO) initiated with an Outperform at William Blair. 5. Intuitive Surgical (ISRG) initiated with a Buy at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
AAPL Apple
$200.19

-0.46 (-0.23%)

04/10/19
04/10/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Reduce from Hold at HSBC with analyst Erwan Rambourg saying the returns from Apple's recent announcements, including the Apple News+ premium news subscription, the Apple Card in partnership with Goldman Sachs (GS), Apple Arcade games as part of the App store and video subscription Apple TV+, could "take some time to extract." 2. AmerisourceBergen (ABC) downgraded to In Line from Outperform at Evercore ISI with analyst Michael Cherry citing group profit questions, lack of clarity with PharMEDium, and a reduction in multiple for peers Cardinal Health (CAH) and McKesson (MCK). 3. Novartis (NVS) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Mark Purcell saying the spinoff of Alcon will put more attention on the generics risk Novartis faces in its pharma business. 4. TerraForm Power (TERP) downgraded to Sell from Neutral at Goldman Sachs with analyst Brian Lee saying that while the company is in the midst of an operational transition that may improve cash flow and dividend flexibility, the upside appears to be priced in. 5. Foot Locker (FL) assumed with a Neutral from Buy at Citi with analyst Paul Lejuez saying while Foot Locker has "tailwinds at its back" in North America with comps inflecting positively in Q4, the company still faces many of the same headwinds as other specialty retailers given its "significant" mall exposure and EBIT pressure from direct-to-consumer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/19
FBCO
04/11/19
INITIATION
Target $209
FBCO
Neutral
Apple initiated with a Neutral at Credit Suisse
Credit Suisse analyst Matt Cabral started coverage of Apple with a Neutral rating and a $209 price target. The analyst believes the push to monetize Apple's installed base through Services holds potential, but argues that it will take time to shift investor perception versus double-digit iPhone declines and at a peak P/E multiple.
04/11/19
JPMS
04/11/19
NO CHANGE
JPMS
Overweight
iPhone supplier tracker improved in March, says JPMorgan
JPMorgan analyst Samik Chatterjee says his iPhone supplier tracker improved in March. Aggregate iPhone revenues returned to growth in the month of March, "supporting recent anecdotal evidence of bottoming out of headwinds," Chatterjee tells investors in a research note. Month-over-month, aggregate revenues rose by 34% in March, following four months of sequential declines, and compares to a 21% increase seen historically going from the month of February to March, says the analyst. On a quarterly basis, Chatterjee says iPhone supplier aggregate revenues decelerated to 2% year-over-year in Q1 from up 7% in Q4 of 2018. The deceleration in supplier revenue growth points to continued iPhone revenue declines in Q2, albeit to a lesser degree, contends the analyst.
04/11/19
KEYB
04/11/19
NO CHANGE
KEYB
Apple iPhone inventory/demand remains stable, says KeyBanc
KeyBanc analyst John Vinh says his latest carrier checks indicate Apple (AAPL) iPhone inventories have stabilized in March with sell-through tracking largely in line with stores' expectation. Meanwhile, feedback on the Samsung (SSNLF) GS10 has been "overwhelmingly positive," as most stores believe the new features have been a factor in driving sales, and keeping inventories at healthy levels, he contends. Given stabilizing iPhone trends and better than expected GS10 demand, the analyst sees favorable risk/reward for the mobile supply chain. Vinh recommends investors buy Broadcom (AVGO) and Qorvo (QRVO).
DELL Dell Technologies
$63.36

0.09 (0.14%)

03/01/19
SBSH
03/01/19
NO CHANGE
Target $70
SBSH
Buy
Dell Technologies price target raised to $70 from $55 at Citi
Citi analyst Jim Suva raised his price target for Dell Technologies to $70 saying the company reported "solid" results with guidance slightly above expectations. The company plans to de-lever its debt which will help lower interest costs and increase cash flows, and investors are underestimating this positive benefit, Suva tells investors in a post-earnings research note. He maintains a Buy rating on Dell Technologies.
04/11/19
FBCO
04/11/19
INITIATION
Target $65
FBCO
Neutral
Dell Technologies initiated with a Neutral at Credit Suisse
Credit Suisse analyst Matt Cabral started coverage of Dell Technologies with a Neutral rating and a $65 price target. The analyst acknowledges the company's "solid execution" in 2018, but notes that high leverage leaves little room for error and constrains capital allocation for years to come.
03/04/19
BMOC
03/04/19
NO CHANGE
Target $52
BMOC
Market Perform
Dell Technologies price target raised to $52 from $48 at BMO Capital
BMO Capital analyst Tim Long raised his price target on Dell Technologies to $52 after its in-line Q4 revenues and higher than expected operating margins. The analyst is also positive on the company's expectations for its Servers and Storage business but expects those markets to "become more challenged through the year", keeping his Market Perform rating on the shares.
03/04/19
MAXM
03/04/19
NO CHANGE
MAXM
Hold
VMware's AWS synergies likely priced in, says Maxim
Maxim analyst Nehal Chokshi kept his Hold rating on VMWare (VMW) and removed his $155 price target, saying the company's higher than expected license revenue was driven by the "overachievement" from its Dell (DELL) synergies. The analyst believes that VMWare's guidance also implies "slowing incremental Dell synergies and accelerating AWS (AMZN) synergies", which he sees as likely "priced in".
HPQ HP Inc.
$19.96

-0.015 (-0.08%)

04/11/19
FBCO
04/11/19
INITIATION
Target $21
FBCO
Neutral
HP Inc. initiated with a Neutral at Credit Suisse
Credit Suisse analyst Matt Cabral started coverage of HP Inc. with a Neutral rating and a $21 price target. The analyst sees supplies as a "key concern" following the disappointing inventory reset, despite "steady" gains on PC share and free cash flow.
02/28/19
02/28/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Booking Holdings (BKNG) downgraded to Neutral from Overweight at Atlantic Equities and Piper Jaffray, as well as to Perform from Outperform at Oppenheimer. 2. Box (BOX) downgraded to Sector Weight from Overweight at KeyBanc and to Neutral from Buy at Rosenblatt. 3. HP Inc. (HPQ) double downgraded to Underperform from Buy at BofA/Merrill with analyst Wamsi Mohan citing the company's Q1 report last night. 4. PSEG (PEG) downgraded to Hold from Buy at Deutsche Bank. 5. Dollar General (DG) and Big Lots (BIG) were downgraded to Hold from Buy at Deutsche Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/28/19
BOFA
02/28/19
DOWNGRADE
Target $19
BOFA
Underperform
BofA double downgrades HP Inc. to Underperform after earnings
As previously reported, BofA analyst Wamsi Mohan downgraded HP Inc. two notches, to Underperform from Buy, following the company's Q1 report last night. His prior thesis was built on expectations for stability in high margin print supplies, which he now has lower confidence in, he tells investors. Mohan sees volatility in supplies growth leading to lower confidence in predictability and he thinks the company's unchanged guidance looks high given the shortfall in supplies. He also worries about cash flow headwinds from higher restructuring costs and investments while calling out the risk of an incremental PC slowdown. Mohan cut his price target on HP Inc. shares to $19 from $30.
02/28/19
BOFA
02/28/19
DOWNGRADE
BOFA
Underperform
HP Inc. downgraded to Underperform from Buy at BofA/Merrill
YETI Yeti
$30.93

0.79 (2.62%)

04/11/19
COWN
04/11/19
INITIATION
Target $35
COWN
Outperform
Yeti initiated with an Outperform at Cowen
Cowen analyst John Kernan started Yeti Holdings with an Outperform rating and $35 price target. Consensus sales and earnings estimates appear conservative as the company's shift to direct-to-consumer accelerates, Kernan tells investors in a research note. Further, implied estimates around wholesale and international segments suggest additional conservatism, adds the analyst. He notes the lock-up period on insider shares ends on April 22.
03/29/19
MSCO
03/29/19
DOWNGRADE
Target $32
MSCO
Equal Weight
Morgan Stanley downgrades Yeti to Equal Weight after stock doubled year-to-date
Morgan Stanley analyst Kimberly Greenberger downgraded Yeti to Equal Weight from Overweight, stating that while she remains constructive on the company's long-term outlook, she sees much of the good news being priced in with the stock having advanced 115% year-to-date. The stock, which has risen 77% above its IPO price from last October, appears to be pricing in 5-plus years of mid-teens percentage revenue growth, which compares to her base case estimate of 11% growth, Greenberger tells investors. She raised her price target on Yeti shares to $32 from $26, driven by an increased multiple as peers have re-rated higher.
03/29/19
MSCO
03/29/19
DOWNGRADE
MSCO
Equal Weight
Yeti downgraded to Equal Weight from Overweight at Morgan Stanley
03/22/19
JEFF
03/22/19
NO CHANGE
Target $40
JEFF
Buy
Yeti price target raised to $40 from $35 at Jefferies
Jefferies analyst Randal Konik raised his price target for Yeti (YETI) to $40 from $35 and keeps a Buy rating on the shares. The analyst says his analysis of search trends and store checks indicates the Yeti brand "is becoming increasingly sought after, and brand reach is expanding." The company is gaining traction in new colorways, cooler demand is strengthening, shelf space at Dick's (DKS) is growing, and e-commerce conversion is improving, Konik tells investors in a research note. He raised his 2020 estimates, believes Yeti is in the early stages of global growth and that its shares will continue to move higher.
CVS CVS Health
$54.15

0.27 (0.50%)

04/10/19
CANT
04/10/19
NO CHANGE
CANT
Senate hearing a net positive for PBMs, says Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper views yesterday's Senate hearing as a net positive for the pharmacy benefit managers. The PBMs represented were Cigna (CI), CVS Health (CVS), UnitedHealth (UNH), Humana (HUM) and Prime Therapeutics. Although the Senators were not supportive of the PBMs, the executives responded well to questions and put forth a solid effort to address concerns regarding their business model and incentives, Halper tells investors in a research note. Overall, he views the hearing as a net positive for PBMs "as the group was able to counter the negative sentiment with constructive responses, recognizing this story is far from over."
04/10/19
RHCO
04/10/19
NO CHANGE
RHCO
SunTrust lowers price targets on CVS, raises price target on WellCare
SunTrust analyst David MacDonald lowered his price target on CVS (CVS) to $65 from $85 as part of his broader research note previewing Q1 results for the healthcare services stocks. The analyst expects the quarter to reflect the company's challenges around reimbursement pressure, fewer generics, and lower brand inflation that should be a detriment to retail pharmacy and long-term-care businesses, even though he maintains a bullish view on the stock longer term based on its risk-reward profile. MacDonald also raises his price target on WellCare (WCG) to $340 from $305, saying his bullish expectation for the stock is driven by the company's "strong core trends, high visibility, and superb win rate". The analyst also cites the pending WellCare acquisition by Centene (CNC) yielding a "meaningful combined pharmacy opportunity and increased diversification" from an expanded "Medicaid footprint".
04/10/19
BMOC
04/10/19
INITIATION
BMOC
Market Perform
CVS Health initiated with a Market Perform at BMO Capital
BMO Capital analyst Matt Borsch initiated CVS Health with a Market Perform rating and a $58 price target. The analyst said that he is aware of the low valuation of the stock, but is "wary of further deterioration in the outlook given headwinds on CVS legacy businesses that have recently intensified," and is not confident "the pressures will diminish next year."
04/03/19
MSCO
04/03/19
NO CHANGE
MSCO
Morgan Stanley says Walgreens' reimbursement pressure points to distributor risk
Morgan Stanley analyst Ricky Goldwasser said the guidance cut made by Walgreens Boots Alliance (WBA) is due to the same "perfect storm of industry headwinds" addressed by CVS Health (CVS) earlier in the year, including increased reimbursement pressure, lower generic deflation, lower brand inflation and declining comparable sales in the front-end of the store. Though Walgreens management suggested reimbursement headwinds should normalize in fiscal 2020, Goldwasser said he could see more downside from continued reimbursement headwinds and structural changes if new rebate rule comes into play. He also views pharmacy reimbursement pressure as a leading indicator suggesting risk to distributors' sell side margins and earnings, including for AmerisourceBergen (ABC), which Goldwasser notes is part of the WBAD purchasing consortium. Other drug distributors include McKesson (MCK) and Cardinal Health (CAH).
CSIQ Canadian Solar
$18.49

-0.28 (-1.49%)

04/11/19
JPMS
04/11/19
INITIATION
Target $22
JPMS
Neutral
Canadian Solar assumed with a Neutral at JPMorgan
JPMorgan analyst Mark Strouse assumed coverage of Canadian Solar (CSIQ) with a Neutral rating and $22 price target. The rating is unchanged and the target is raised from $21 relative to the firm's prior coverage. The analyst believes Canadian Solar is "approximately fairly valued" pending improved visibility and prefer shares of First Solar (FSLR).
02/12/19
BOFA
02/12/19
NO CHANGE
BOFA
First Solar, Canadian Solar likely to beat quarter estimates, says BofA/Merrill
BofA/Merrill analyst Brian Lee says that despite the strong year-to-date outperformance across the group, he would lean into solar stocks heading into Q4 earnings as he sees momentum likely to persist for stocks that can beat, namely First Solar (FLSR) and Canadian Solar (CSIQ). Fundamentally, the analyst expects a much more constructive tone from companies heading into 2019, and sees both companies as best positioned to beat given First Solar's better margins and Canadian Solar's project sales that consensus is not capturing. On the flipside, Lee reiterates a Sell rating on SolarEdge (SEDG), which he sees as having the highest idiosyncratic risk and lower estimates owing to recent M&A that appears both dilutive and a key investor focus point.
03/14/19
GSCO
03/14/19
NO CHANGE
GSCO
Buy
Goldman Sachs sees 'brighter future', 'rising demand' in global solar sector
Goldman Sachs analyst Brian Lee writes that the outperformance of the U.S. solar sector early in 2019 highlights its better than expected positive inflection of demand trends, also raising his demand forecast for the next 3 years by an average of 10%-15%. Lee says his top ideas are First Solar (FSLR), Canadian Solar (CSIQ), and Vivint Solar (VSLR), which he rates at Buy with respective $64, $26, and $6.50 price targets. Although solar stocks have "rebounded sharply off of last year's depressed levels", Lee notes that fundamentals are still in the early stages of a cyclical recovery amid signs of pricing stabilization and demand trends gathering momentum.
03/01/19
STPT
03/01/19
DOWNGRADE
STPT
Hold
Canadian Solar downgraded to Hold from Buy at Standpoint Research

TODAY'S FREE FLY STORIES

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$3.88

(0.00%)

16:36
05/24/19
05/24
16:36
05/24/19
16:36
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 18

    Jun

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:35
05/24/19
05/24
16:35
05/24/19
16:35
Syndicate
Breaking Syndicate news story on Toronto-Dominion »

Toronto-Dominion files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
05/24/19
05/24
16:30
05/24/19
16:30
Options
Preliminary option volume of 15.7M today »

Preliminary option volume…

CBUS

Cibus

$0.00

(0.00%)

16:25
05/24/19
05/24
16:25
05/24/19
16:25
Syndicate
Cibus requests withdrawal of registration statement »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$355.14

4.57 (1.30%)

16:23
05/24/19
05/24
16:23
05/24/19
16:23
Periodicals
Boeing 737 MAX return delayed by FAA expanding review, WSJ reports »

A review of Boeing's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

FB

Facebook

$181.03

0.14 (0.08%)

, BA

Boeing

$355.14

4.57 (1.30%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. stocks, which had a…

FB

Facebook

$181.03

0.14 (0.08%)

BA

Boeing

$355.14

4.57 (1.30%)

UAL

United Continental

$80.77

-0.14 (-0.17%)

SMI

SMIC

$5.23

-0.26 (-4.74%)

HPQ

HP Inc.

$20.03

0.835 (4.35%)

HPE

HP Enterprise

$14.36

0.03 (0.21%)

NVS

Novartis

$87.49

3.03 (3.59%)

CNC

Centene

$56.84

1.39 (2.51%)

WCG

WellCare

$275.45

0.99 (0.36%)

TSS

TSYS

$113.42

13.81 (13.86%)

GPN

Global Payments

$153.42

5.45 (3.68%)

HIBB

Hibbett Sports

$23.91

4.07 (20.51%)

DVAX

Dynavax

$5.77

-0.59 (-9.28%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

SPLK

Splunk

$119.13

-9.55 (-7.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 13

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 24th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/24/19
05/24
16:17
05/24/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/24/19
05/24
16:16
05/24/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHE

Regional Health Properties

$2.06

0.09 (4.57%)

16:15
05/24/19
05/24
16:15
05/24/19
16:15
Hot Stocks
Regional Health Properties receives NYSE notice over late Form 10-Q filing »

Regional Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBIO

Translate Bio

$9.12

-0.09 (-0.98%)

16:14
05/24/19
05/24
16:14
05/24/19
16:14
Syndicate
Breaking Syndicate news story on Translate Bio »

Translate Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.